In this article, Gregory Vistnes outlines why Antitrust Agencies care about clinical integration, an issue that might seem primarily an issue of concern to the healthcare community and not antitrust enforcers, and how the agencies typically evaluate the competitive significance of clinical integration.
Broadcom/VMware: Navigating foreclosure theories across different jurisdictions
This case presented numerous conceptual challenges, notably the differing outcomes of the competitive assessments across 12 jurisdictions. While Broadcom was...